文献速递前列腺癌

双参数与多参数MRI诊断前列腺癌准确性头对头比较的系统综述与双变量荟萃分析

Head-to-head comparison of diagnostic test accuracy between biparametric and multiparametric MRI: an updated systematic review and bivariate meta-analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2025-07-22

Mp-MRI汇总敏感度0.90、特异度0.64,Bp-MRI汇总敏感度0.89、特异度0.73,sROC曲线重叠,荟萃回归未见显著差异。结论认为Bp-MRI可作为Mp-MRI的可行替代,尤其当对比剂使用受限时。

要点

  • Bp-MRI与Mp-MRI检测CsPCa的诊断准确性相当,sROC曲线重叠。
  • Mp-MRI汇总敏感度0.90、特异度0.64;Bp-MRI为0.89与0.73。
  • 荟萃回归未发现两种方法间有统计学显著差异。

核心结论

  • Bp-MRI检测CsPCa的诊断准确性可与Mp-MRI媲美,是可行的替代方案,尤其在对比剂使用存在顾虑时。

主要发现

  • Mp-MRI检测CsPCa的汇总敏感度为0.90(95% CI:0.87-0.93),汇总特异度为0.64(95% CI:0.50-0.76)。
  • Bp-MRI检测CsPCa的汇总敏感度为0.89(95% CI:0.85-0.92),汇总特异度为0.73(95% CI:0.62-0.82)。
  • 两种方法的sROC曲线重叠,荟萃回归显示两者诊断准确性无统计学显著差异,研究水平协变量未影响结果。

临床怎么用

  • 在对比剂使用受限或患者不愿接受DCE序列时,可考虑以Bp-MRI替代Mp-MRI检测CsPCa。

局限性

  • 结论基于现有研究,仍需进一步前瞻性随机研究予以证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate Cancer (PCa) is a leading cause of cancer-related mortality globally. Clinically significant PCa (CsPCa) is associated with more aggressive disease, making accurate diagnosis crucial. Multiparametric Magnetic Resonance Imaging (Mp-MRI) is a well-established tool for PCa detection, but the dynamic contrast-enhanced (DCE) sequence raises concerns due to cost, risks, and patient experience. Biparametric MRI (Bp-MRI) has emerged as an alternative, but its diagnostic performance compared to Mp-MRI has not been thoroughly examined through a systematic review and meta-analysis in recent years. METHODS: A systematic review and meta-analysis were conducted to compare the diagnostic accuracy of Bp-MRI and Mp-MRI for detecting CsPCa by assessing the databases MEDLINE/PubMed, CENTRAL Cochrane, and ClinicalTrials.gov. Studies published between 2012 and 2024 that compared Bp-MRI and Mp-MRI using histopathological analysis as the reference standard were included. Data were extracted to obtain diagnostic test accuracy measurements (sensitivity, specificity, diagnostic odds ratio, positive and negative likelihood ratios) and study characteristics. Statistical analysis involved two bivariate random-effects models, a summary Receiver Operating Characteristic (sROC) curve, and meta-regression models assessing the comparison of both diagnostic test accuracies and the interaction of different study-level covariates. RESULTS: Nineteen studies involving 5,173 patients were included. Mp-MRI demonstrated a pooled sensitivity of 0.90 (95% CI: 0.87-0.93) and a specificity of 0.64 (95% CI: 0.50-0.76), while Bp-MRI showed a pooled sensitivity of 0.89 (95% CI: 0.85-0.92) and a specificity of 0.73 (95% CI: 0.62-0.82). Both modalities showed similar diagnostic performance with overlapping sROC curves. Meta-regression revealed no statistically significant difference between the two tools, and the study-level covariates did not influence the results. CONCLUSION: Bp-MRI is a viable alternative to Mp-MRI for detecting CsPCa, with comparable diagnostic accuracy, especially when contrast agents are a concern. Further prospective randomized studies are needed to confirm these findings. REGISTRY: PROSPERO (CRD42024552125).

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Garcia-Becerra CA, Arias-Gallardo MI, Juarez-Garcia JE, et al. Head-to-head comparison of diagnostic test accuracy between biparametric and multiparametric MRI: an updated systematic review and bivariate meta-analysis. Prostate Cancer Prostatic Dis. 2025. PMID: 40696165. doi:10.1038/s41391-025-00999-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。